Patent ID: 9655880
Date: 2017-05-23
CPC Classifications: A61K,A61P,C07D

Claim:
1. A method for the therapeutic treatment of breast cancer comprising administering to a patient a therapeutically effective amount of a pharmaceutical composition comprising an (S)-enantiomer compound that has the following structure of Formula (III): wherein, each R each R n is 1, 2, or 3; or a pharmaceutically acceptable salt, and one or more pharmaceutically acceptable inactive ingredients selected from carriers, excipients, binders, filling agents, suspending agents, flavoring agents, sweetening agents, disintegrating agents, dispersing agents, surfactants, lubricants, colorants, diluents, solubilizers, moistening agents, plasticizers, stabilizers, penetration enhancers, wetting agents, anti-foaming agents, antioxidants, and preservatives.